Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
29 March 2022 | Story Teli Mothabeng | Photo Supplied
Philmon Bitso, Student Recruitment Officer, with the top-10 cohort of the class of 2021 Free State Star of Stars.

The Department of Student Recruitment Services at the University of the Free State (UFS) hosted its annual Free State Star of Stars competition at the Amanzi Private Game Reserve during the first week of March.  The event saw some of the brightest young minds in the Free State inducted as UFS first-year students into this year’s top-10 cohort for the competition. This marks the first Star of Stars event since the beginning of the COVID-19 pandemic. 


This new cohort consists of a dynamic group of academically gifted students from Quintile 1-3 schools in the Free State who are currently enrolled for different UFS academic programmes, ranging from Medicine, Law, Education, and various Bachelor of Science courses. Many of these students had to overcome insurmountable challenges to perform as well as they did in their Grade 12 academic year and to become part of the top-10 cohort for the class of 2021. Due to the COVID-19 pandemic, the Department of Student Recruitment Services was forced to take a different approach to celebrate these deserving students; consequently, a weekend-long induction camp was the substitute for the annual gala dinner. 

Apply for the 2022 Free State Star of Stars competition

The UFS realised the need to establish a platform that recognises and celebrates the diverse and, in most instances, difficult circumstances that disadvantaged schools (Quintile 1-3) are facing. Consequently, the Star of Stars competition was developed and established in 2016. This competition provides disadvantaged Grade 12 learners from all districts in the Free State an opportunity to showcase their excellence, while motivating them to aspire to achieve more.

Star of Stars Flyer 2022  aplicayion for the 2022 Free State Star of Stars competition open on 1 April 2022.

News Archive

Researchers receive study grant for research into Congo Fever
2015-03-10

UFS researchers will be contributing significantly to the search for a vaccine against the deadly tick-borne disease known as Congo Fever.

Prof Felicity Burt from the Department of Medical Microbiology and Virology was recently awarded a research grant by the National Health Laboratory Service (NHLS) to study candidate vaccines for Crimean-Congo heamorrhagic fever (CCHF) virus and other arboviruses.

Arboviruses are viruses transmitted by mosquitoes, ticks, or other arthropods.

Prof Burt is an internationally-recognised expert on the Crimean-Congo haemorrhagic fever (CCHF). The Crimean-Congo haemorrhagic fever (CCHF) virus is a tick-borne virus that is associated with severe haemorrhagic disease in South Africa and other parts of Africa, Asia, and eastern Europe. Her interests focus on medically significant viruses that are transmitted by ticks and mosquitoes. Her research group is involved in determining the immune responses that are induced by different viral proteins.

Crimean-Congo haemorrhagic fever (CCHF) virus, a tick- borne virus found in Africa, Asia, the Balkans, and eastern Europe, causes severe viral haemorrhagic fever outbreaks.

Although a number of tick species are capable of becoming infected with CCHF virus, ticks of the genus Hyalomma, commonly referred to in SA as the “bont-legged ticks”, are the principal vector. The ticks have distinctive brown and white bands on their legs.

In February 1981, the first case of CCHF was recognised in South Africa (SA). To date, there have been nearly 200 cases of CCHF infection in SA with a 20% fatality rate. The majority of cases occurring in SA were in patients from the Northern Cape and Free State provinces.

“The funding that has been awarded will be used to profile immune responses against CCHF viral proteins, and investigate mechanisms and strategies to enhance these immune responses. We hope that the study will contribute knowledge towards the development of a vaccine against this medically significant virus.”

For more information or enquiries contact news@ufs.ac.za.

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept